Annual Accounts Payable
$17.40 M
+$5.42 M+45.26%
31 December 2023
Summary:
Corcept Therapeutics Incorporated annual accounts payable is currently $17.40 million, with the most recent change of +$5.42 million (+45.26%) on 31 December 2023. During the last 3 years, it has risen by +$10.49 million (+151.82%). CORT annual accounts payable is now at all-time high.CORT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$18.58 M
-$900.00 K-4.62%
30 September 2024
Summary:
Corcept Therapeutics Incorporated quarterly accounts payable is currently $18.58 million, with the most recent change of -$900.00 thousand (-4.62%) on 30 September 2024. Over the past year, it has increased by +$1.19 million (+6.83%). CORT quarterly accounts payable is now -4.62% below its all-time high of $19.48 million, reached on 30 June 2024.CORT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CORT Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +6.8% |
| 3 y3 years | +151.8% | +169.0% |
| 5 y5 years | +130.8% | +146.6% |
CORT Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +151.8% | -4.6% | +169.0% |
| 5 y | 5 years | at high | +151.8% | -4.6% | +273.5% |
| alltime | all time | at high | +3068.7% | -4.6% | >+9999.0% |
Corcept Therapeutics Incorporated Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.58 M(-4.6%) |
| June 2024 | - | $19.48 M(+55.2%) |
| Mar 2024 | - | $12.56 M(-27.8%) |
| Dec 2023 | $17.40 M(+45.3%) | $17.40 M(+4.1%) |
| Sept 2023 | - | $16.71 M(+109.5%) |
| June 2023 | - | $7.98 M(-28.9%) |
| Mar 2023 | - | $11.22 M(-6.3%) |
| Dec 2022 | $11.98 M(+73.4%) | $11.98 M(+46.4%) |
| Sept 2022 | - | $8.18 M(-0.8%) |
| June 2022 | - | $8.25 M(-11.0%) |
| Mar 2022 | - | $9.27 M(+34.2%) |
| Dec 2021 | $6.91 M(-34.5%) | $6.91 M(+5.3%) |
| Sept 2021 | - | $6.56 M(-28.8%) |
| June 2021 | - | $9.22 M(+32.2%) |
| Mar 2021 | - | $6.97 M(-34.0%) |
| Dec 2020 | $10.55 M(+40.0%) | $10.55 M(+62.1%) |
| Sept 2020 | - | $6.51 M(+3.3%) |
| June 2020 | - | $6.30 M(+26.7%) |
| Mar 2020 | - | $4.98 M(-34.0%) |
| Dec 2019 | $7.54 M(-8.8%) | $7.54 M(+26.9%) |
| Sept 2019 | - | $5.94 M(-15.5%) |
| June 2019 | - | $7.03 M(-24.7%) |
| Mar 2019 | - | $9.33 M(+12.9%) |
| Dec 2018 | $8.27 M(-3.6%) | $8.27 M(-40.6%) |
| Sept 2018 | - | $13.92 M(+118.7%) |
| June 2018 | - | $6.37 M(-18.9%) |
| Mar 2018 | - | $7.85 M(-8.5%) |
| Dec 2017 | $8.58 M(+274.6%) | $8.58 M(+37.8%) |
| Sept 2017 | - | $6.23 M(+199.0%) |
| June 2017 | - | $2.08 M(-51.0%) |
| Mar 2017 | - | $4.25 M(+85.7%) |
| Dec 2016 | $2.29 M(+72.8%) | $2.29 M(-46.9%) |
| Sept 2016 | - | $4.31 M(+107.1%) |
| June 2016 | - | $2.08 M(-0.0%) |
| Mar 2016 | - | $2.08 M(+57.1%) |
| Dec 2015 | $1.32 M(-29.7%) | $1.32 M(-23.9%) |
| Sept 2015 | - | $1.74 M(-26.3%) |
| June 2015 | - | $2.36 M(+127.8%) |
| Mar 2015 | - | $1.04 M(-45.1%) |
| Dec 2014 | $1.89 M | $1.89 M(-3.8%) |
| Sept 2014 | - | $1.96 M(-24.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $2.60 M(-29.2%) |
| Mar 2014 | - | $3.67 M(+54.0%) |
| Dec 2013 | $2.38 M(-37.4%) | $2.38 M(+1.9%) |
| Sept 2013 | - | $2.34 M(-22.9%) |
| June 2013 | - | $3.03 M(+34.0%) |
| Mar 2013 | - | $2.26 M(-40.5%) |
| Dec 2012 | $3.80 M(+5.3%) | $3.80 M(+141.7%) |
| Sept 2012 | - | $1.57 M(-62.8%) |
| June 2012 | - | $4.24 M(+103.2%) |
| Mar 2012 | - | $2.08 M(-42.3%) |
| Dec 2011 | $3.61 M(+342.0%) | $3.61 M(+238.7%) |
| Sept 2011 | - | $1.07 M(-53.5%) |
| June 2011 | - | $2.29 M(+22.8%) |
| Mar 2011 | - | $1.86 M(+128.3%) |
| Dec 2010 | $817.00 K(-35.7%) | $817.00 K(-30.3%) |
| June 2010 | - | $1.17 M(+14.7%) |
| Mar 2010 | - | $1.02 M(-19.4%) |
| Dec 2009 | $1.27 M(-2.6%) | $1.27 M(+42.4%) |
| Sept 2009 | - | $892.00 K(+33.1%) |
| June 2009 | - | $670.00 K(-57.4%) |
| Mar 2009 | - | $1.57 M(+20.5%) |
| Dec 2008 | $1.30 M(+17.0%) | $1.30 M(+30.0%) |
| Sept 2008 | - | $1.00 M(-8.7%) |
| June 2008 | - | $1.10 M(+25.1%) |
| Mar 2008 | - | $878.00 K(-21.3%) |
| Dec 2007 | $1.11 M(+21.7%) | $1.11 M(-33.1%) |
| Sept 2007 | - | $1.67 M(+444.4%) |
| June 2007 | - | $306.00 K(-62.2%) |
| Mar 2007 | - | $809.00 K(-11.7%) |
| Dec 2006 | $916.00 K(+66.8%) | $916.00 K(-65.0%) |
| Sept 2006 | - | $2.62 M(+107.0%) |
| June 2006 | - | $1.26 M(+2.8%) |
| Mar 2006 | - | $1.23 M(+124.2%) |
| Dec 2005 | $549.00 K(-0.2%) | $549.00 K(-34.1%) |
| Sept 2005 | - | $833.00 K(+566.4%) |
| June 2005 | - | $125.00 K(-56.1%) |
| Mar 2005 | - | $285.00 K(-48.2%) |
| Dec 2004 | $550.00 K | $550.00 K(-43.9%) |
| Sept 2004 | - | $980.50 K(+55.7%) |
| June 2004 | - | $629.80 K(-32.7%) |
| Mar 2004 | - | $935.80 K |
FAQ
- What is Corcept Therapeutics Incorporated annual accounts payable?
- What is the all time high annual accounts payable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly accounts payable?
- What is the all time high quarterly accounts payable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly accounts payable year-on-year change?
What is Corcept Therapeutics Incorporated annual accounts payable?
The current annual accounts payable of CORT is $17.40 M
What is the all time high annual accounts payable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual accounts payable is $17.40 M
What is Corcept Therapeutics Incorporated quarterly accounts payable?
The current quarterly accounts payable of CORT is $18.58 M
What is the all time high quarterly accounts payable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly accounts payable is $19.48 M
What is Corcept Therapeutics Incorporated quarterly accounts payable year-on-year change?
Over the past year, CORT quarterly accounts payable has changed by +$1.19 M (+6.83%)